Lahat N, Aghai E, Maroun B, Kinarty A, Quitt M, Froom P
Immunology Unit, Kupat Holim Lady Davis Carmel Hospital, Haifa, Israel.
Clin Exp Immunol. 1991 Aug;85(2):302-6. doi: 10.1111/j.1365-2249.1991.tb05723.x.
We studied B cells from 18 patients with B-CLL, six of them with autoimmune haemolytic anaemia, for spontaneous secretion of IL-6. Our aim was to determine whether the increased incidence of autoimmune disease found in B-CLL patients is associated with enhanced spontaneous IL-6 secretion. IL-6 was measured by the effect of B cell supernatants on the proliferation of an IL-6 dependent plasmacytoma cell line T1165. The highest IL-6 values (7.4 +/- 1.8 U/ml) were measured in supernatants derived on day 3 of culture from lymphocytes of the six patients with B-CLL and concomitant autoimmune disease. The maximal IL-6 values for 10 patients with B-CLL only were 2.8 +/- 0.3 U/ml and for 10 age-matched controls, 0.8 +/- 0.3 U/ml (P less than 0.01, each group compared with the other). We conclude that there is an association between B-CLL, autoimmune disease and the spontaneous in vitro secretion of IL-6. Further studies are needed to determine whether the IL-6 secretion plays a role in the pathogenesis of autoimmune disease in patients with B-CLL.
我们研究了18例B细胞慢性淋巴细胞白血病(B-CLL)患者的B细胞,其中6例患有自身免疫性溶血性贫血,检测其白细胞介素-6(IL-6)的自发分泌情况。我们的目的是确定B-CLL患者中自身免疫性疾病发病率的增加是否与自发IL-6分泌增强有关。通过B细胞上清液对依赖IL-6的浆细胞瘤细胞系T1165增殖的影响来检测IL-6。在培养第3天从6例患有B-CLL并伴有自身免疫性疾病患者的淋巴细胞获得的上清液中测得最高的IL-6值(7.4±1.8 U/ml)。仅患有B-CLL的10例患者的最大IL-6值为2.8±0.3 U/ml,10例年龄匹配的对照者为0.8±0.3 U/ml(每组与另一组相比,P<0.01)。我们得出结论,B-CLL、自身免疫性疾病与体外自发分泌IL-6之间存在关联。需要进一步研究以确定IL-6分泌是否在B-CLL患者自身免疫性疾病的发病机制中起作用。